Transparency · Governance · Trust

Understand the rules before the work begins.

A single source for how microscopIA approaches data, pricing, partnerships, authorship, publication, research integrity, and innovation responsibility.

Project-specific agreements remain authoritative when their terms are more specific than this public framework.

01Data governance02Pricing03Partnerships04Authorship05Publication06IP & innovation

Public governance framework

Six commitments that make collaboration understandable and accountable.

The same framework supports institutional, clinician-led, education-supported, and innovation projects.

01

Data governance

Purpose limitation, minimum necessary data, lawful access, de-identification, secure transfer, role-based access, retention, deletion, and incident response.

02

Research ethics & integrity

Feasibility, protocol quality, ethics, reproducibility, conflicts, reporting, correction pathways, and protection from inappropriate practices.

03

Authorship & contributorship

Authorship is earned through documented contribution and accountability. Payment or project access does not confer authorship.

04

Publication transparency

Journal strategy, indexing, processing charges, peer-review risk, editorial independence, and no acceptance guarantee are stated clearly.

05

Partnership governance

Every agreement defines responsibilities, deliverables, timelines, decision rights, confidentiality, data permissions, financial terms, and termination.

06

Responsible AI, devices & IP

Clinical AI and devices require defined intended use, human oversight, validation, monitoring, and project-specific IP terms. AI may support triage and prioritisation; diagnosis and care decisions remain human responsibilities.

Clinical data governance

Data access follows purpose, permission, and necessity.

Do not submit identifiable patient data through a general contact form. Work begins only after the data source, authority, permitted purpose, safeguards, and responsibilities are established.

01

Before transfer

Confirm provenance, controller, permissions, ethics, variables, criteria, and secure transfer.

02

During analysis

Use minimum necessary data, role-based access, documented transformations, reproducibility, and confidentiality.

03

At completion

Apply retention or deletion terms, preserve approved records, document outputs, and prevent unapproved reuse.

Pricing transparency

Regional pricing built around the evidence, not the passport.

One scientific standard, with Colombia pricing in COP and Americas and international pricing in USD. Prices apply to a complete, ready-to-start research package and are confirmed after feasibility review.

Colombia: more than 80% of submitter authors must hold Colombian affiliations and the proposal must arrive by day 10 of the call cycle. Americas: more than 80% must hold affiliations in countries of the Americas outside Colombia and the proposal must arrive by day 10. Americas prices are fixed commercial rates exactly USD 100 above the USD reference for each Colombia tier (fixed COP 4,000/USD basis; not a live currency conversion). Otherwise, the international rate applies.

Evidence typeColombiaAmericasInternational
Case reportCOP 2,000,000USD 600USD 1,200
Retrospective studyCOP 3,500,000USD 975USD 2,900
Prospective studyCOP 4,500,000USD 1,225USD 3,600
Economic evaluationCOP 5,000,000USD 1,350USD 4,400
Completed clinical trialCOP 6,000,000USD 1,600USD 5,500
Completed community pilotCOP 5,500,000USD 1,475USD 4,800

Outcome-aligned payment

The fee contributes to team salaries and the eligible article processing charge; microscopIA absorbs the remaining delivery cost. This model aligns incentives but cannot control an independent journal decision.

0150% after approval

Due after microscopIA approves the proposal and the agreement is signed. Work begins after receipt.

0250% after journal acceptance

Due only after formal acceptance for publication. If none of the five-journal pathway accepts the manuscript, the second payment is not due.

+Additional authors

USD 150 for each qualifying submitter author above the included limit. Colombian projects are invoiced in the COP equivalent.

8 weeks

From ready-to-start confirmation to manuscript submission

+ COP 1,200,000 · Americas USD 400 · International USD 500

Priority delivery in 4 weeks

+ COP 1,200,000 · Americas USD 400 · International USD 500

Case reports only: rapid delivery in 10 business days

The clock starts after ethics/authorization review, a complete analysable dataset or case file, variable dictionary, contributor details, secure-transfer approval, and first payment. It pauses while essential partner input is outstanding. Journal peer review and acceptance are excluded.

What the base price covers

Scientific lead and project coordinationEpidemiology, clinical-data, economic, or geospatial analysis as scopedInterpretation, tables, figures, and reporting-guideline compliant manuscriptIterative scientific improvements, journal reformatting, reviewer responses, and sequential submission to as many as five journalsmicroscopIA corresponding-author coordination throughout the editorial pathwayEligible mandatory article processing charge for the approved journal, paid directly after acceptance and invoice verificationData collection, recruitment, ethics fees, and optional services excluded unless separately scopedJournal acceptance is never guaranteed

Partnership models

Different arrangements. Explicit responsibilities.

Each project uses the model that best reflects who contributes data, scientific work, infrastructure, funding, oversight, technology, or implementation capacity.

01

Scientific collaboration

The submitter provides governed data and clinical expertise; microscopIA leads the remaining scientific workflow; both teams publish together.

02

Contracted research

Scope, fee, deliverables, decision rights, and publication pathway are agreed in writing.

03

Education-supported research

Participation fees support training, supervision, infrastructure, and eligible publication costs—not authorship.

04

Innovation partnership

Development, validation, IP, inventor recognition, licensing, and publication rights are project-specific.

05

Satellite research department

A recurring model supports portfolio selection, protocols, analytics, publishing, and internal capacity.

06

Books and chapters

Chapter development and medical-book editing are available by request and priced after an editorial assessment.

Authorship & editorial decisions

You publish with microscopIA—not through an anonymous manuscript-preparation service.

Qualifying submitter authors occupy the first positions: up to five for a case report and up to eight for every other output. Additional qualifying submitter authors cost USD 150 each; Colombian projects are billed in COP equivalent.

microscopIA reserves the final four positions for qualifying microscopIA contributors and designates the corresponding author to coordinate submission, peer review, and publication.

microscopIA contributors may be network members or supervised students and professionals enrolled in educational programmes. Every proposed author must sign the declaration and meet the journal’s authorship criteria; payment or enrolment alone never confers authorship.

Journal-specific author limits and policies remain controlling. Each author may use no more than two affiliations other than microscopIA, formatted as Department, Organisation, City, Country.

Download authorship declaration

Trust Center FAQ

Questions that should be answered before signature or payment.

01Does microscopIA guarantee publication?

No. Journals retain independent authority. The second 50% is due only after acceptance to align payment with the intended outcome.

02Are article processing charges included?

Yes. microscopIA pays 100% of an eligible mandatory article processing charge for the approved journal directly after acceptance and invoice verification. Optional services are excluded unless agreed.

03Can data be used for another project?

Only when permissions, ethics, the written agreement, and purpose allow it. A new question does not create automatic authority.

04How are conflicts or integrity concerns handled?

Concerns are documented and reviewed. Action can include revision, role changes, suspension, termination, correction, or institutional escalation.

05What if a journal rejects the manuscript?

microscopIA evaluates the decision, improves and reformats the work, and may submit sequentially to as many as five appropriate journals. A sixth pathway requires a new written scope.

Clarity before commitment

Request the documents relevant to your partnership.

A formal collaboration may require a scope, data terms, authorship plan, participation terms, IP schedule, and financial proposal.